Skip to main content

Pacira BioSciences, Inc.

PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001396814

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Pacira BioSciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
258
−7 vs. Q1 2023
Shares held
47.0M
+684.2K (+1.5%) vs. Q1 2023
Total value
$1.88B
−$8.25M (−0.4%) vs. Q1 2023
New holders
34
95 more added
Sold out
41
94 more reduced

3 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 258 institutions
Q1 2021: 270 institutionsQ2 2021: 261 institutionsQ3 2021: 260 institutionsQ4 2021: 276 institutionsQ1 2022: 301 institutionsQ2 2022: 285 institutionsQ3 2022: 272 institutionsQ4 2022: 273 institutionsQ1 2023: 268 institutionsQ2 2023: 258 institutionsQ3 2023: 262 institutionsQ4 2023: 261 institutionsQ1 2024: 271 institutionsQ2 2024: 282 institutionsQ3 2024: 239 institutionsQ4 2024: 233 institutionsQ1 2025: 235 institutionsQ2 2025: 233 institutionsQ3 2025: 239 institutionsQ4 2025: 261 institutionsQ1 2026: 242 institutionsQ2 2026: 254 institutions
Value heldQ2 2023: $1.88B
Q1 2021: $3.49BQ2 2021: $2.99BQ3 2021: $2.75BQ4 2021: $3.05BQ1 2022: $3.79BQ2 2022: $2.85BQ3 2022: $2.67BQ4 2022: $1.87BQ1 2023: $1.89BQ2 2023: $1.88BQ3 2023: $1.46BQ4 2023: $1.63BQ1 2024: $1.44BQ2 2024: $1.48BQ3 2024: $772.1MQ4 2024: $940.6MQ1 2025: $1.26BQ2 2025: $1.21BQ3 2025: $1.24BQ4 2025: $1.22BQ1 2026: $986.2MQ2 2026: $1.11B
Institutions holding PCRX and their total value by quarter
QuarterHoldersValue
Q2 2026254$1.11B
Q1 2026242$986.2M
Q4 2025261$1.22B
Q3 2025239$1.24B
Q2 2025233$1.21B
Q1 2025235$1.26B
Q4 2024233$940.6M
Q3 2024239$772.1M
Q2 2024282$1.48B
Q1 2024271$1.44B
Q4 2023261$1.63B
Q3 2023262$1.46B
Q2 2023258$1.88B
Q1 2023268$1.89B
Q4 2022273$1.87B
Q3 2022272$2.67B
Q2 2022285$2.85B
Q1 2022301$3.79B
Q4 2021276$3.05B
Q3 2021260$2.75B
Q2 2021261$2.99B
Q1 2021270$3.49B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Pacira BioSciences, Inc.; share changes are against Q1 2023.

Institutions holding PCRX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Stonnington Group, LLC––––Not filed
Pathway Financial Advisers, LLC––––Not filed